Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Spondylitis and CYP2C9[original query] |
---|
Influence of CYP2C9 and COX-2 Genetic Polymorphisms on Clinical Efficacy of Non-Steroidal Anti-Inflammatory Drugs in Treatment of Ankylosing Spondylitis. Medical science monitor : international medical journal of experimental and clinical research 2017 Apr 23 1775-1782. Wang Yu, Yi Xiao-Dong, Lu Hai-L |
Correlations of CYP2C9*3/CYP2D6*10/CYP3A5*3 gene polymorphisms with efficacy of etanercept treatment for patients with ankylosing spondylitis: A case-control study. Medicine 2017 Mar 96 (9): e5993. Chen Yuan-Yu |
Physiologically based pharmacokinetic (PBPK) modeling for prediction of celecoxib pharmacokinetics according to CYP2C9 genetic polymorphism. Archives of pharmacal research 2021 Jul 44 (7): 713-724. Kim Young-Hoon, Kang Pureum, Cho Chang-Keun, Jung Eui Hyun, Park Hye-Jeong, Lee Yun Jeong, Bae Jung-Woo, Jang Choon-Gon, Lee Seok-Yo |
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 25, 2024
- Content source: